reslizumab - CAS 241473-69-8
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
COA:
Inquire
Targets:
Interleukin Related
Description:
Reslizumab is a humanized monoclonal antibody resistant to interleukin-5 (IL-5). It is approved for additional maintenance treatment of patients with severe asthma aged 18 years and older, and with an eosinophilic phenotype.
Brife Description:
humanized monoclonal antibody, IL-5, asthma
Synonyms:
Cinqair
MSDS:
Inquire
Application:
the treatment of severe asthma
Current Developer:
Teva
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Interleukin Related Products


reslizumab
(CAS: 241473-69-8)

Reslizumab is a humanized monoclonal antibody resistant to interleukin-5 (IL-5). It is approved for additional maintenance treatment of patients with severe ast...

CAS 86727-00-6 CK 17

CK 17
(CAS: 86727-00-6)

CK 17 is a interleukin-1 antagonist. It can suppress fibroblast proliferation.

CAS 197917-10-5 CK-119

CK-119
(CAS: 197917-10-5)

CK-119, a dihydropyridazino-pyridazine compound, is a potent IL-1 blocker to inhibit cell growth of fibroblast-like corneal and conjunctival cells mainly throug...

CAS 870087-36-8 Apilimod mesylate

Apilimod mesylate
(CAS: 870087-36-8)

The mesylate salt form of Apilimod. Apilimod is a potent and orally-available inhibitor of the cytokines interleukin-12 (IL-12) and interleukin-23 (IL-23) with ...

CAS 114727-43-4 SU 5201

SU 5201
(CAS: 114727-43-4)

SU 5201 is an inhibitor of IL-2 production.

Secukinumab
(CAS: 875356-43-7)

Secukinumab is a recombinant human IgG1κ monoclonal antibody that specifically binds to and inhibits interleukin (IL)-17A. Secukinumab was developed by Novartis...

CAS 94055-76-2 Suplatast Tosylate

Suplatast Tosylate
(CAS: 94055-76-2)

Suplatast Tosilate is a novel capsular anti-asthmatic agent that suppresses both IgE production, IL-4 and IL-5 synthesis with IC50 above 100 μM.

CAS 849776-05-2 Ladarixin

Ladarixin
(CAS: 849776-05-2)

Ladarixin is Interleukin 8A and Interleukin 8B receptor antagonist. IL-8A and IL-8B inhibition blocks and reverses type 1 diabetes in mice. In Dec 2015, Phase-I...

Quick Inquiry

Verification code

Featured Items